Operating
Depreciation
Gilead Sciences Depreciation increased by 3.3% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.1%, from $97.00M to $93.00M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 3.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher depreciation relative to capital expenditures may suggest aging assets, while lower levels relative to revenue may indicate high asset efficiency.
Detailed definition
Depreciation is a non-cash accounting charge that allocates the cost of tangible assets over their useful lives. It refl...
Peer comparison
Standardized for capital-intensive industries; peers in manufacturing typically show significant depreciation expenses.
Metric ID:
operating_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $79.00M | $82.00M | $90.00M | $80.00M | $80.00M | $80.00M | $83.00M | $94.00M | $83.00M | $86.00M | $91.00M | $94.00M | $98.00M | $94.00M | $95.00M | $97.00M | $93.00M | $90.00M | $90.00M | $93.00M |
| QoQ Change | — | +3.8% | +9.8% | -11.1% | +0.0% | +0.0% | +3.8% | +13.3% | -11.7% | +3.6% | +5.8% | +3.3% | +4.3% | -4.1% | +1.1% | +2.1% | -4.1% | -3.2% | +0.0% | +3.3% |
| YoY Change | — | — | — | — | +1.3% | -2.4% | -7.8% | +17.5% | +3.8% | +7.5% | +9.6% | +0.0% | +18.1% | +9.3% | +4.4% | +3.2% | -5.1% | -4.3% | -5.3% | -4.1% |
Range$79.00M – $98.00M
CAGR+3.5%
Avg YoY Growth+2.9%
Median YoY Growth+2.2%
Current Streak2 quarters growth
Depreciation at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's depreciation?
- Gilead Sciences (GILD) reported depreciation of $93.00M in Q1 2026.
- How has Gilead Sciences's depreciation changed year-over-year?
- Gilead Sciences's depreciation decreased by 4.1% year-over-year, from $97.00M to $93.00M.
- What is the long-term trend for Gilead Sciences's depreciation?
- Over 4 years (2021 to 2025), Gilead Sciences's depreciation has grown at a 3.0% compound annual growth rate (CAGR), from $329.00M to $370.00M.
- What does depreciation mean?
- The systematic reduction in the recorded value of physical assets over time.